资产负债表（Matinas BioPharma Holdings Inc）
| 2024年中报 | 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | ||||||||||
| 现金及现金等价物(元) | 4,216,000.00 | 1,071,000.00 | 4,787,000.00 | 6,407,000.00 | 9,743,000.00 | 5,739,000.00 | 6,830,000.00 | 11,175,838.00 | 10,398,544.00 | 19,328,135.00 |
| 受限制存款及现金流动(元) | 50,000.00 | 50,000.00 | 50,000.00 | 50,000.00 | 50,000.00 | 50,000.00 | 50,000.00 | 50,000.00 | 50,000.00 | 50,000.00 |
| 预付款项及其他应收款流动(元) | 922,000.00 | 2,129,000.00 | 1,737,000.00 | 1,723,000.00 | 1,437,000.00 | 3,299,000.00 | 5,719,000.00 | 3,997,798.00 | 3,371,538.00 | 1,199,111.00 |
| 短期投资(元) | 10,097,000.00 | 7,039,000.00 | 8,969,000.00 | 11,809,000.00 | 12,770,000.00 | 19,118,000.00 | 21,933,000.00 | 21,875,015.00 | 28,104,146.00 | 24,541,834.00 |
| 流动资产合计(元) | 15,285,000.00 | 10,289,000.00 | 15,543,000.00 | 19,989,000.00 | 24,000,000.00 | 28,206,000.00 | 34,532,000.00 | 37,098,651.00 | 41,924,228.00 | 45,119,080.00 |
| 非流动资产： | ||||||||||
| 物业、厂房及设备(元) | 1,739,000.00 | 1,829,000.00 | 1,923,000.00 | 2,021,000.00 | 2,103,000.00 | 1,998,000.00 | 2,091,000.00 | 2,144,102.00 | 1,982,975.00 | 2,013,322.00 |
| 受限制存款及现金非流动(元) | 200,000.00 | 200,000.00 | 200,000.00 | 200,000.00 | 200,000.00 | 200,000.00 | 200,000.00 | 200,000.00 | 200,000.00 | 200,000.00 |
| 商誉(元) | 1,336,000.00 | 1,336,000.00 | 1,336,000.00 | 1,336,000.00 | 1,336,000.00 | 1,336,000.00 | 1,336,000.00 | 1,336,488.00 | 1,336,488.00 | 1,336,488.00 |
| 非流动资产其他项目(元) | 5,805,000.00 | 5,956,000.00 | 6,102,000.00 | 6,245,000.00 | 6,386,000.00 | 6,522,000.00 | 6,660,000.00 | 6,766,422.00 | 6,971,950.00 | 7,115,975.00 |
| 非流动资产合计(元) | 9,080,000.00 | 9,321,000.00 | 9,561,000.00 | 9,802,000.00 | 10,025,000.00 | 10,056,000.00 | 10,287,000.00 | 10,447,012.00 | 10,491,413.00 | 10,665,785.00 |
| 总资产(元) | 24,365,000.00 | 19,610,000.00 | 25,104,000.00 | 29,791,000.00 | 34,025,000.00 | 38,262,000.00 | 44,819,000.00 | 47,545,663.00 | 52,415,641.00 | 55,784,865.00 |
| 流动负债： | ||||||||||
| 融资租赁负债流动(元) | 712,000.00 | 686,000.00 | 661,000.00 | 637,000.00 | 613,000.00 | 589,000.00 | 569,000.00 | 547,936.00 | - | - |
| 应付账款及票据(元) | 238,000.00 | 473,000.00 | 514,000.00 | 835,000.00 | 604,000.00 | 516,000.00 | 618,000.00 | 656,717.00 | 497,151.00 | 1,351,905.00 |
| 其他应付款及应计费用(元) | 1,442,000.00 | 839,000.00 | 1,447,000.00 | 1,757,000.00 | 1,372,000.00 | 791,000.00 | 3,099,000.00 | 3,696,932.00 | 4,294,396.00 | 1,840,748.00 |
| 流动负债其他项目(元) | - | - | - | - | - | - | - | - | 590,768.00 | 575,836.00 |
| 流动负债合计(元) | 2,392,000.00 | 1,998,000.00 | 2,622,000.00 | 3,229,000.00 | 2,589,000.00 | 1,896,000.00 | 4,286,000.00 | 4,901,585.00 | 5,382,315.00 | 3,768,489.00 |
| 非流动负债： | ||||||||||
| 融资租赁负债非流动(元) | 2,529,000.00 | 2,713,000.00 | 2,895,000.00 | 3,071,000.00 | 3,241,000.00 | 3,400,000.00 | 3,555,000.00 | 3,683,949.00 | - | - |
| 递延所得税负债非流动(元) | 341,000.00 | 341,000.00 | 341,000.00 | 341,000.00 | 341,000.00 | 341,000.00 | 341,000.00 | 341,265.00 | 341,265.00 | 341,265.00 |
| 非流动负债其他项目(元) | - | - | - | - | - | - | - | - | 3,843,524.00 | 3,993,396.00 |
| 非流动负债合计(元) | 2,870,000.00 | 3,054,000.00 | 3,236,000.00 | 3,412,000.00 | 3,582,000.00 | 3,741,000.00 | 3,896,000.00 | 4,025,214.00 | 4,184,789.00 | 4,334,661.00 |
| 总负债(元) | 5,262,000.00 | 5,052,000.00 | 5,858,000.00 | 6,641,000.00 | 6,171,000.00 | 5,637,000.00 | 8,182,000.00 | 8,926,799.00 | 9,567,104.00 | 8,103,150.00 |
| 股东权益： | ||||||||||
| 普通股(元) | 25,000.00 | 22,000.00 | 22,000.00 | 22,000.00 | 22,000.00 | 22,000.00 | 22,000.00 | 21,685.00 | 21,685.00 | 21,685.00 |
| 股本溢价(元) | 206,245,000.00 | 196,067,000.00 | 195,018,000.00 | 193,746,000.00 | 192,550,000.00 | 191,342,000.00 | 190,070,000.00 | 188,529,404.00 | 187,116,333.00 | 185,901,685.00 |
| 留存收益(元) | -187,116,000.00 | -181,397,000.00 | -175,573,000.00 | -170,259,000.00 | -164,204,000.00 | -158,144,000.00 | -152,631,000.00 | -148,996,657.00 | -143,535,065.00 | -137,612,481.00 |
| 累计其他全面收益(元) | -51,000.00 | -134,000.00 | -221,000.00 | -359,000.00 | -514,000.00 | -595,000.00 | -824,000.00 | -935,568.00 | -754,416.00 | -629,174.00 |
| 归属于母公司股东权益(元) | 19,103,000.00 | 14,558,000.00 | 19,246,000.00 | 23,150,000.00 | 27,854,000.00 | 32,625,000.00 | 36,637,000.00 | 38,618,864.00 | 42,848,537.00 | 47,681,715.00 |
| 股东权益合计(元) | 19,103,000.00 | 14,558,000.00 | 19,246,000.00 | 23,150,000.00 | 27,854,000.00 | 32,625,000.00 | 36,637,000.00 | 38,618,864.00 | 42,848,537.00 | 47,681,715.00 |
| 负债及股东权益合计(元) | 24,365,000.00 | 19,610,000.00 | 25,104,000.00 | 29,791,000.00 | 34,025,000.00 | 38,262,000.00 | 44,819,000.00 | 47,545,663.00 | 52,415,641.00 | 55,784,865.00 |
| 公告日期 | 2024-08-14 | 2024-05-09 | 2024-03-27 | 2023-11-08 | 2023-08-09 | 2023-05-10 | 2023-03-15 | 2022-11-02 | 2022-08-11 | 2022-05-12 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||||
| 核数师 |